{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:06:11Z","timestamp":1792649171611,"version":"4.5.0"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jgar.2020.01.022","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T17:27:58Z","timestamp":1581528478000},"page":"161-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"C","title":["Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: Back to the future"],"prefix":"10.1016","volume":"22","author":[{"given":"Arezoo","family":"Asadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Kouhsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Panahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Sholeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourkhoda","family":"Sadeghifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghi","family":"Amiriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2020.01.022_bib0005","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1474-4422(04)00937-8","article-title":"The promise of minocycline in neurology","volume":"3","author":"Yong","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","article-title":"Minocycline and neurodegenerative diseases","author":"Kim","year":"2009","journal-title":"Behav Brain"},{"key":"10.1016\/j.jgar.2020.01.022_bib0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/08959374980120011901","article-title":"Chemical and biological dynamics of tetracyclines","volume":"12","author":"Nelson","year":"1998","journal-title":"Adv Dent Res"},{"key":"10.1016\/j.jgar.2020.01.022_bib0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2004.07.012","article-title":"Clinical potential of minocycline for neurodegenerative disorders","volume":"17","author":"Blum","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jgar.2020.01.022_bib0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2133.2003.05497.x","article-title":"Minocycline: stain devil?","volume":"149","author":"Good","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/AAC.8.6.713","article-title":"Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs","volume":"8","author":"Barza","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.01.022_bib0040","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/cpt1978234467","article-title":"Tetracycline absorption in elderly patients with achlorhydria","volume":"23","author":"Kramer","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jgar.2020.01.022_bib0045","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/cpt1973145852","article-title":"Pharmacokinetic studies on minocycline in man","volume":"14","author":"Macdonald","year":"1973","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jgar.2020.01.022_bib0050","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido\u2010Mesa","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0055","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2015","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.jgar.2020.01.022_bib0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2146\/ajhp150290","article-title":"IV minocycline revisited for infections caused by multidrug\u2013resistant organisms","volume":"73","author":"Colton","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jgar.2020.01.022_bib0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12941-015-0085-1","article-title":"Global in vitro activity of tigecycline and comparator agents: tigecycline evaluation and surveillance trial 2004\u20132013","volume":"14","author":"Hoban","year":"2015","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jgar.2020.01.022_bib0070","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.01.022_bib0075","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/jac\/30.6.737","article-title":"Efflux-based antibiotic resistance mechanisms: the evidence for increasing prevalence","volume":"30","author":"Chopra","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.01.022_bib0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10096-017-3081-x","article-title":"Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations","volume":"37","author":"Cunha","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2020.01.022_bib0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1086\/313604","article-title":"Minocycline versus doxycycline in the treatment of Lyme neuroborreliosis","volume":"30","author":"Cunha","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2020.01.022_bib0090","series-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","article-title":"Design and optimization of dosage regimens: pharmacokinetic data","author":"Tummel","year":"2001"},{"key":"10.1016\/j.jgar.2020.01.022_bib0095","first-page":"47","article-title":"Minocycline hydrochloride: the emerging evidence of its therapeutic value in complicated bacterial infections","volume":"3","author":"Vanderloo","year":"2011","journal-title":"Clin Med Rev Ther"},{"key":"10.1016\/j.jgar.2020.01.022_bib0100","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2133.1996.tb06972.x","article-title":"Safety of long-term high-dose minocycline in the treatment of acne","volume":"134","author":"Goulden","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0105","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3346\/jkms.2010.25.8.1231","article-title":"A case of anaphylaxis to oral minocycline","volume":"25","author":"Jang","year":"2010","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jgar.2020.01.022_bib0110","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/00912700122010753","article-title":"The risk of liver damage associated with minocycline: a comparative study","volume":"41","author":"Seaman","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0115","doi-asserted-by":"crossref","first-page":"ofv107","DOI":"10.1093\/ofid\/ofv107","article-title":"Minocycline-induced cutaneous hyperpigmentation in an orthopedic patient population","volume":"3","author":"Hanada","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2020.01.022_bib0120","first-page":"492","article-title":"Minocycline\u2013induced hyperpigmentation","volume":"118","author":"Skorin","year":"2018","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.jgar.2020.01.022_bib0125","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jama.1980.03310100021021","article-title":"Minocycline\u2013induced pigmentation at sites of cutaneous inflammation","volume":"244","author":"Fenske","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2020.01.022_bib0130","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/sj.bdj.4809867","article-title":"Oral and systemic effects of prolonged minocycline therapy","volume":"185","author":"Patel","year":"1998","journal-title":"Br Dent J"},{"key":"10.1016\/j.jgar.2020.01.022_bib0135","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0022-3565(25)39508-X","article-title":"The minocycline-induced thyroid pigment and several synthetic models: identification and characterization by electron paramagnetic resonance spectroscopy","volume":"266","author":"Enochs","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jgar.2020.01.022_bib0140","first-page":"33","article-title":"A brown\u2013eyed woman with blue discoloration of the sclera","volume":"72","author":"Bosma","year":"2014","journal-title":"Neth J Med"},{"key":"10.1016\/j.jgar.2020.01.022_bib0145","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/archderm.1980.01640350052013","article-title":"Skin pigmentation secondary to minocycline therapy","volume":"116","author":"McGrae","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/RHU.0b013e31816356d1","article-title":"Minocycline-induced hyperpigmentation in rheumatoid arthritis","volume":"14","author":"Fay","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40257-018-0393-2","article-title":"An update on drug-induced pigmentation","volume":"20","author":"Nahhas","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0160","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","article-title":"Safety of doxycycline and minocycline: a systematic review","volume":"27","author":"Smith","year":"2005","journal-title":"Clin Ther"},{"issue":"8","key":"10.1016\/j.jgar.2020.01.022_bib0165","article-title":"Minocycline for acne vulgaris: efficacy and safety","author":"Garner","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgar.2020.01.022_bib0170","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1212\/NXI.0000000000000180","article-title":"Vasculitic neuropathy following exposure to minocycline","volume":"3","author":"Baratta","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jgar.2020.01.022_bib0175","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.39048.540394.BE","article-title":"Don\u2019t use minocycline as first line oral antibiotic in acne","volume":"334","author":"McManus","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jgar.2020.01.022_bib0180","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/MEG.0b013e3282f493c5","article-title":"Minocycline hepatitis","volume":"20","author":"Ford","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0185","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40121-017-0153-2","article-title":"Minocycline for the treatment of multidrug and extensively drug-resistant A. baumannii: a review","volume":"6","author":"Lashinsky","year":"2017","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jgar.2020.01.022_bib0190","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1128\/jb.174.24.7926-7933.1992","article-title":"Genetic analysis of the tetA (C) gene on plasmid pBR322","volume":"174","author":"McNicholas","year":"1992","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0195","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijantimicag.2009.06.021","article-title":"Minocycline\u2014an old drug for a new century: emphasis on methicillin\u2013resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii","volume":"34","author":"Bishburg","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.01.022_bib0200","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/1574-6968.12410","article-title":"Minocycline resistance in an oral Streptococcus infantis isolate is encoded by tet(S) on a novel small, low copy number plasmid","volume":"353","author":"Ciric","year":"2014","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.jgar.2020.01.022_bib0205","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.vetmic.2012.10.002","article-title":"Evaluation of minocycline susceptibility of methicillin-resistant Staphylococcus pseudintermedius","volume":"162","author":"Weese","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0210","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01176-17","article-title":"Acinetobacter baumanniiContribution of the TetB efflux pump to minocycline susceptibility among carbapenem-resistant strains","volume":"61","author":"Wang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.01.022_bib0215","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/AAC.01388-10","article-title":"Efflux-mediated antibiotic resistance in Acinetobacter spp","volume":"55","author":"Coyne","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.01.022_bib0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fmicb.2011.00040","article-title":"Environmental macrolide-lincosamide-streptogramin and tetracycline-resistant bacteria","volume":"2","author":"Roberts","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0225","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.resmic.2004.10.008","article-title":"Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals","volume":"156","author":"Huys","year":"2005","journal-title":"Res Microbiol"},{"issue":"Suppl. 1","key":"10.1016\/j.jgar.2020.01.022_bib0230","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/ofid\/ofw172.1591","article-title":"TetB testing and its absence identifies minocycline (MINO) susceptible isolates of Acinetobacter baumannii (ACB)","volume":"3","author":"Lomovskaya","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2020.01.022_bib0235","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/mdr.2000.6.277","article-title":"Mutations in the interdomain loop region of the tetA (A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines","volume":"6","author":"Tuckman","year":"2000","journal-title":"Microbial Drug Resist"},{"key":"10.1016\/j.jgar.2020.01.022_bib0240","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1097-2765(01)00238-6","article-title":"Localization of the ribosomal protection protein Tet (O) on the ribosome and the mechanism of tetracycline resistance","volume":"7","author":"Spahn","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.jgar.2020.01.022_bib0245","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.femsle.2005.02.034","article-title":"Update on acquired tetracycline resistance genes","volume":"245","author":"Roberts","year":"2005","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.jgar.2020.01.022_bib0250","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/367622","article-title":"Tetracycline therapy: update","volume":"36","author":"Eliopoulos","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2020.01.022_bib0255","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1128\/AAC.47.7.2310-2312.2003","article-title":"Presence of the Tet M determinant in a clinical isolate of Acinetobacter baumannii","volume":"47","author":"Ribera","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.01.022_bib0260","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1099\/00222615-40-3-214","article-title":"Multidrug resistance to antiseptics and disinfectants in coagulase\u2013negative staphylococci","volume":"40","author":"Leelaporn","year":"1994","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0265","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1128\/AAC.50.4.1550-1551.2006","article-title":"Genetic basis of tetracycline and minocycline resistance in potentially probiotic Lactobacillus plantarum strain CCUG 43738","volume":"50","author":"Huys","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.01.022_bib0270","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0147-619X(02)00118-X","article-title":"Lactobacillus plantarumCharacterization of the tetracycline resistance plasmid pMD5057 from 5057 reveals a composite structure","volume":"48","author":"Danielsen","year":"2002","journal-title":"Plasmid"},{"key":"10.1016\/j.jgar.2020.01.022_bib0275","doi-asserted-by":"crossref","first-page":"7173","DOI":"10.1128\/AEM.69.12.7173-7180.2003","article-title":"Heat shock treatment increases the frequency of loss of an erythromycin resistance-encoding transposable element from the chromosome of Lactobacillus crispatus CHCC3692","volume":"69","author":"Str\u00f8man","year":"2003","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0280","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1128\/AEM.69.2.1270-1275.2003","article-title":"Molecular characterization of tet (M) genes in Lactobacillus isolates from different types of fermented dry sausage","volume":"69","author":"Gevers","year":"2003","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0285","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/AAC.01751-12","article-title":"Emergence and spread of plasmid-borne tet (B):: ISCR2 in minocycline-resistant Acinetobacter baumannii isolates","volume":"57","author":"Vilacoba","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.01.022_bib0290","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical Laboratory Standards Institute","year":"2019"},{"key":"10.1016\/j.jgar.2020.01.022_bib0295","series-title":"Breakpoint tables for interpretation of MICs and zone diameters","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2019"},{"key":"10.1016\/j.jgar.2020.01.022_bib0300","series-title":"Tygacil (tigecycline) for injection","author":"Wyeth","year":"2010"},{"key":"10.1016\/j.jgar.2020.01.022_bib0305","series-title":"Antimicrobial stewardship: from principles to practice","author":"British Society for Antimicrobial Chemotherapy","year":"2018"},{"key":"10.1016\/j.jgar.2020.01.022_bib0310","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0924-8579(94)90034-5","article-title":"Minocycline: old and new therapeutic uses","volume":"4","author":"Freeman","year":"1994","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.01.022_bib0315","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1128\/AAC.00561-11","article-title":"In vitro antibacterial activity of NB\u2013003 against Propionibacterium acnes","volume":"55","author":"Pannu","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.01.022_bib0320","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1007\/s00134-003-1811-2","article-title":"Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia","volume":"29","author":"Wood","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jgar.2020.01.022_bib0325","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2011"},{"key":"10.1016\/j.jgar.2020.01.022_bib0330","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/microorganisms7060159","article-title":"The role of minocycline in the treatment of nosocomial infections caused by multidrug, extensively drug and pandrug-resistant Acinetobacter baumannii: a systematic review of clinical evidence","volume":"7","author":"Fragkou","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.jgar.2020.01.022_bib0335","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/ipc.0b013e318159d595","article-title":"Minocycline therapy for traumatic wound infections caused by the multidrug-resistant Acinetobacter baumannii\u2013Acinetobacter calcoaceticus complex","volume":"16","author":"Griffith","year":"2008","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.jgar.2020.01.022_bib0340","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1017\/S0950268815002897","article-title":"Widespread dispersion of the resistance element tet (B):: ISCR2 in XDR Acinetobacter baumannii isolates","volume":"144","author":"Vilacoba","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jgar.2020.01.022_bib0345","first-page":"195","article-title":"Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: a study in western Iran","volume":"5","author":"Mohajeri","year":"2013","journal-title":"Iran J Microbiol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0350","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ijantimicag.2018.04.006","article-title":"Absence of TetB identifies minocycline-susceptible isolates of Acinetobacter baumannii","volume":"52","author":"Lomovskaya","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.01.022_bib0355","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijantimicag.2017.03.012","article-title":"Carbapenem-resistant Enterobacteriaceae in the community: a scoping review","volume":"50","author":"Kelly","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.01.022_bib0360","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jhm.2477","article-title":"Acinetobacter baumanniiSecular trends in resistance in respiratory and bloodstream specimens in the United States, 2003 to 2012: a survey study","volume":"11","author":"Zilberberg","year":"2016","journal-title":"J Hosp Med"},{"key":"10.1016\/j.jgar.2020.01.022_bib0365","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhin.2017.07.015","article-title":"Prevalence of, and risk factors for, carriage of carbapenem-resistant Enterobacteriaceae among hospitalized patients in Japan","volume":"97","author":"Yamamoto","year":"2017","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jgar.2020.01.022_bib0370","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jinf.2010.03.001","article-title":"Global monitoring of cross-resistance between tigecycline and minocycline, 2004\u20132009","volume":"60","author":"Hawser","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.jgar.2020.01.022_bib0375","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cimid.2013.03.004","article-title":"Prevalence and antimicrobial susceptibility of Salmonella isolates in Pekin ducks from South Korea","volume":"36","author":"Cha","year":"2013","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2020.01.022_bib0380","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/mdr.2016.0043","article-title":"Minocycline and tigecycline: what is their role in the treatment of carbapenem-resistant gram-negative organisms?","volume":"23","author":"Shankar","year":"2017","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jgar.2020.01.022_bib0385","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ijantimicag.2006.10.019","article-title":"Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial","volume":"29","author":"DiPersio","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.01.022_bib0390","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ijantimicag.2011.07.010","article-title":"BacteroidesInvestigation of the prevalence of tetQ, tetX and tetX1 genes in strains with elevated tigecycline minimum inhibitory concentrations","volume":"38","author":"Bartha","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.01.022_bib0395","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s10096-016-2745-2","article-title":"Ureaplasma urealyticumPrevalence and antibiotic susceptibility of and Mycoplasma hominis in Xi\u2019an, China","volume":"35","author":"Zeng","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2020.01.022_bib0400","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1523-5378.2009.00714.x","article-title":"Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan","volume":"14","author":"Horiki","year":"2009","journal-title":"Helicobacter"},{"key":"10.1016\/j.jgar.2020.01.022_bib0405","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/tid.12001","article-title":"Prevalence of multidrug-resistant gram-negative bacilli producing extended-spectrum \u03b2-lactamases (ESBLs) and ESBL genes in solid organ transplant recipients","volume":"15","author":"Men","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jgar.2020.01.022_bib0410","first-page":"925","article-title":"Investigation of the genetic basis of tetracycline resistance in Staphylococcus aureus from Pakistan","volume":"11","author":"Ullah","year":"2012","journal-title":"Trop J Pharm Res"},{"key":"10.1016\/j.jgar.2020.01.022_bib0415","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ijantimicag.2013.08.006","article-title":"Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections","volume":"42","author":"Cunha","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.01.022_bib0420","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1468-3083.2011.04351.x","article-title":"Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong","volume":"27","author":"Luk","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0425","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2165\/00128071-200304120-00002","article-title":"Is antibiotic resistance in cutaneous propionibacteria clinically relevant?","volume":"4","author":"Eady","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0430","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0140-6736(04)17591-0","article-title":"Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial","volume":"364","author":"Ozolins","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2020.01.022_bib0435","first-page":"873","article-title":"Common and alternate oral antibiotic therapies for acne vulgaris: a review","volume":"6","author":"Amin","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0440","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2133.2003.05067.x","article-title":"Antibiotic-resistant acne: lessons from Europe","volume":"148","author":"Ross","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0445","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1586\/14787210.2015.1040765","article-title":"Antibiotic resistance to Propionobacterium acnes: worldwide scenario, diagnosis and management","volume":"13","author":"Sardana","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jgar.2020.01.022_bib0450","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1099\/jmm.0.035477-0","article-title":"Serotypes and antibiotic resistance in Group B streptococcus isolated from patients at the Maternity Hospital, Kuwait","volume":"61","author":"Boswihi","year":"2012","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0455","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.jgar.2020.01.022_bib0460","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.cmi.2015.07.007","article-title":"Minocycline activity against clinical isolates of multidrug-resistant Acinetobacter baumannii","volume":"21","author":"Adibhesami","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2020.01.022_bib0465","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3201\/eid1301.060716","article-title":"Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization","volume":"13","author":"Sunenshine","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2020.01.022_bib0470","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijantimicag.2013.12.010","article-title":"Colistin\/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii","volume":"43","author":"Galani","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.01.022_bib0475","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0005-2736(99)00199-6","article-title":"Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity","volume":"1462","author":"Sitaram","year":"1999","journal-title":"Biochim Biophys Acta (BBA)\u2013Biomembranes"},{"key":"10.1016\/j.jgar.2020.01.022_bib0480","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1469-0691.2006.01601.x","article-title":"Acinetobacter baumanniiMultidrug-resistant bacteraemia: clinical features, antimicrobial therapy and outcome","volume":"13","author":"Kuo","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2020.01.022_bib0485","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.04110-14","article-title":"Assessment of minocycline and polymyxin B combination against Acinetobacter baumannii","volume":"59","author":"Bowers","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.01.022_bib0490","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2334-11-109","article-title":"Activities of colistin- and minocycline-based combinations against extensive drug-resistant Acinetobacter baumannii isolates from intensive care unit patients","volume":"11","author":"Liang","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2020.01.022_bib0495","first-page":"7400","article-title":"Effect of minocycline combined with metronidazole on periodontitis and gingival crevicular fluid cytokines","volume":"11","author":"Han","year":"2018","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jgar.2020.01.022_bib0500","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4103\/jisp.jisp_97_17","article-title":"Tetracycline as local drug delivery in treatment of chronic periodontitis: a systematic review and meta-analysis","volume":"20","author":"Nadig","year":"2016","journal-title":"J Indian Soc Peridontol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0505","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.12149","article-title":"Epidemiology of acne vulgaris","volume":"168","author":"Bhate","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0510","doi-asserted-by":"crossref","first-page":"e9366","DOI":"10.1097\/MD.0000000000009366","article-title":"Efficacy of photodynamic therapy combined with minocycline for treatment of moderate to severe facial acne vulgaris and influence on quality of life","volume":"96","author":"Xu","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.jgar.2020.01.022_bib0515","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1567-1364.2010.00664.x","article-title":"Candida albicansThe combination of minocycline and fluconazole causes synergistic growth inhibition against : an in vitro interaction of antifungal and antibacterial agents","volume":"10","author":"Shi","year":"2010","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.jgar.2020.01.022_bib0520","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41429-017-0024-9","article-title":"In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase\u2013producing K. pneumoniae","volume":"71","author":"Wentao","year":"2018","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.jgar.2020.01.022_bib0525","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11126-017-9515-x","article-title":"Adjunctive minocycline in clozapine-treated patients with schizophrenia: analyzing the effects of minocycline on clozapine plasma levels","volume":"89","author":"Wehring","year":"2018","journal-title":"Psychiatr Q"},{"key":"10.1016\/j.jgar.2020.01.022_bib0530","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/0269881112444941","article-title":"Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment","volume":"26","author":"Chaudhry","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0535","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-017-0073-7","article-title":"Treatment of bipolar depression with minocycline and\/or aspirin: an adaptive, 2 \u00d7 2 double-blind, randomized, placebo-controlled, phase IIA clinical trial","volume":"8","author":"Savitz","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jgar.2020.01.022_bib0540","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13023-018-0891-6","article-title":"A randomized placebo controlled clinical trial to evaluate the efficacy and safety of minocycline in patients with Angelman syndrome (A\u2013MANECE study)","volume":"13","author":"Ruiz-Antoran","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jgar.2020.01.022_bib0545","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12883-014-0232-x","article-title":"An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome","volume":"14","author":"Grieco","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0550","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12879-016-1385-6","article-title":"Role of oral minocycline in acute encephalitis syndrome in India\u2014a randomized controlled trial","volume":"16","author":"Kumar","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2020.01.022_bib0555","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/mds.23236","article-title":"A futility study of minocycline in Huntington\u2019s disease","volume":"25","author":"Huntington Study Group DOMINO Investigators","year":"2010","journal-title":"Move Disord"},{"key":"10.1016\/j.jgar.2020.01.022_bib0560","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1167\/iovs.11-9413","article-title":"Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I\/II clinical study","volume":"53","author":"Cukras","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jgar.2020.01.022_bib0565","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10072-014-1647-2","article-title":"Minocycline improves peripheral and autonomic neuropathy in type 2 diabetes: MIND study","volume":"35","author":"Syngle","year":"2014","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jgar.2020.01.022_bib0570","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00784-011-0535-x","article-title":"Non-surgical periodontal therapy with and without subgingival minocycline administration in patients with poorly controlled type II diabetes: a randomized controlled clinical trial","volume":"16","author":"Lin","year":"2012","journal-title":"Clin Oral Invest"},{"key":"10.1016\/j.jgar.2020.01.022_bib0575","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.joen.2018.07.001","article-title":"Infection control in teeth with apical periodontitis using a triple antibiotic solution or calcium hydroxide with chlorhexidine: a randomized clinical trial","volume":"44","author":"Arruda","year":"2018","journal-title":"J Endodont"},{"key":"10.1016\/j.jgar.2020.01.022_bib0580","first-page":"122","article-title":"Subgingivally applied minocycline microgranules in subjects with chronic periodontitis: a randomized clinical and microbiological trial","volume":"28","author":"Chiappe","year":"2015","journal-title":"Acta Odontol Latinoam"},{"key":"10.1016\/j.jgar.2020.01.022_bib0585","first-page":"ZC15","article-title":"Minocycline ointment as a local drug delivery in the treatment of generalized chronic periodontitis\u2014a clinical study","volume":"10","author":"Abbas","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.jgar.2020.01.022_bib0590","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/YIC.0000000000000098","article-title":"Therapeutic effects of minocycline on mild\u2013to\u2013moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial","volume":"31","author":"Emadi-Kouchak","year":"2016","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0595","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1742-6405-8-17","article-title":"Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study","volume":"8","author":"Ho","year":"2011","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.jgar.2020.01.022_bib0600","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1212\/WNL.0b013e31827b9121","article-title":"Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment","volume":"80","author":"Nakasujja","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jgar.2020.01.022_bib0605","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1212\/WNL.0b013e31822f0412","article-title":"Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial","volume":"77","author":"Sacktor","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jgar.2020.01.022_bib0610","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12404","article-title":"Minocycline in leprosy patients with recent-onset clinical nerve function impairment","volume":"30","author":"Narang","year":"2017","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jgar.2020.01.022_bib0615","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa1608889","article-title":"Trial of minocycline in a clinically isolated syndrome of multiple sclerosis","volume":"376","author":"Metz","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2020.01.022_bib0620","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2377-10-91","article-title":"Open-label add-on treatment trial of minocycline in fragile X syndrome","volume":"10","author":"Paribello","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0625","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/DBP.0b013e318287cd17","article-title":"A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile X syndrome","volume":"34","author":"Leigh","year":"2013","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.jgar.2020.01.022_bib0630","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1681\/ASN.2010121306","article-title":"Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis","volume":"22","author":"Campos","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0635","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/ane.12296","article-title":"An open-label evaluator-blinded clinical study of minocycline neuroprotection in ischemic stroke: gender-dependent effect","volume":"131","author":"Amiri-Nikpour","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jgar.2020.01.022_bib0640","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/AAC.00048-13","article-title":"Mycoplasma pneumoniaeTherapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant pneumonia in pediatric patients","volume":"57","author":"Kawai","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.01.022_bib0645","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/aws072","article-title":"Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury","volume":"135","author":"Casha","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jgar.2020.01.022_bib0650","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaad.2018.08.020","article-title":"A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: results of 2 randomized, double-blind, phase 3 studies","volume":"80","author":"Gold","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0655","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000051728","article-title":"Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris","volume":"203","author":"Dreno","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.jgar.2020.01.022_bib0660","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/01.CCM.0000201404.05523.34","article-title":"A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters","volume":"34","author":"Fraenkel","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jgar.2020.01.022_bib0665","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1227\/NEU.0b013e3182039a14","article-title":"Comparison of two antibiotic-impregnated ventricular catheters: a prospective sequential series trial","volume":"68","author":"Abla","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jgar.2020.01.022_bib0670","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2133.2007.08087.x","article-title":"Community-based study of acne vulgaris in adolescents in Singapore","volume":"157","author":"Tan","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0675","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1346-8138.2012.01626.x","article-title":"Antibiotic resistance of microbial strains isolated from Korean acne patients","volume":"39","author":"Moon","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0680","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1365-4632.2011.05403.x","article-title":"Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia","volume":"52","author":"Mendoza","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0685","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2133.2001.03956.x","article-title":"Phenotypic and genotypic characterization of antibiotic\u2010resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the USA, Japan and Australia","volume":"144","author":"Ross","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0690","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1365-4632.2010.04506.x","article-title":"Report: in vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico","volume":"49","author":"Gonz\u00e1lez","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0695","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1099\/jmm.0.067611-0","article-title":"Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan","volume":"63","author":"Nakase","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0700","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1348-0421.2008.00081.x","article-title":"Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris","volume":"52","author":"Ishida","year":"2008","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0705","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1346-8138.2010.01109.x","article-title":"Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea","volume":"38","author":"Song","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0710","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jmii.2014.06.007","article-title":"Ureaplasma urealyticumPrevalence and antimicrobial susceptibility of and Mycoplasma hominis in female outpatients, 2009\u20132013","volume":"49","author":"Wang","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jgar.2020.01.022_bib0715","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/0022034518818479","article-title":"Surgical therapy of peri-implantitis with local minocycline: a 6-month randomized controlled clinical trial","volume":"98","author":"Cha","year":"2019","journal-title":"J Dent Res"},{"key":"10.1016\/j.jgar.2020.01.022_bib0720","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1748584","article-title":"Effects of antimicrobial photodynamic therapy and local administration of minocycline on clinical, microbiological, and inflammatory markers of periodontal pockets: a pilot study","volume":"2018","author":"Hokari","year":"2018","journal-title":"Int J Dentistry"},{"key":"10.1016\/j.jgar.2020.01.022_bib0725","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1902\/jop.2001.72.11.1535","article-title":"Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial","volume":"72","author":"Williams","year":"2001","journal-title":"J Periodontol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0730","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/0028-3886.93584","article-title":"Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial","volume":"60","author":"Srivastava","year":"2012","journal-title":"Neurol India"},{"key":"10.1016\/j.jgar.2020.01.022_bib0735","first-page":"261","article-title":"Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial","volume":"28","author":"Gunn","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgar.2020.01.022_bib0740","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/0004867417709357","article-title":"Adjunctive minocycline treatment for major depressive disorder: a proof of concept trial","volume":"51","author":"Dean","year":"2017","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.jgar.2020.01.022_bib0745","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40620-014-0152-2","article-title":"Acute kidney injury after cardiac surgery: is minocycline protective?","volume":"28","author":"Golestaneh","year":"2015","journal-title":"J Nephrol"},{"key":"10.1016\/j.jgar.2020.01.022_bib0750","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/ALN.0000000000000508","article-title":"Effect of minocycline on lumbar radicular neuropathic paina randomized, placebo-controlled, double-blind clinical trial with amitriptyline as a comparator","volume":"122","author":"Vanelderen","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jgar.2020.01.022_bib0755","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1161\/STROKEAHA.117.018658","article-title":"Minocycline in acute cerebral hemorrhage: an early phase randomized trial","volume":"48","author":"Fouda","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jgar.2020.01.022_bib0760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173635","article-title":"Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"12","author":"Ishiguro","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jgar.2020.01.022_bib0765","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1866-1955-5-9","article-title":"A pilot open-label trial of minocycline in patients with autism and regressive features","volume":"5","author":"Pardo","year":"2013","journal-title":"J Neurodev Disord"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520300230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520300230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:59:59Z","timestamp":1761991199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716520300230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":153,"alternative-id":["S2213716520300230"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2020.01.022","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: Back to the future","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2020.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}